Potential allergy vaccine boosts hope for sufferers

Australian scientists have developed a potential vaccine for hayfever and other pollen related allergies.

The breakthrough could provide a lifeline to the 25 percent of the world's population suffering severe allergic responses to pollen.

Working with a rye grass protein - one of the most potent environmental allergens known - the team, from the University of Melbourne's Plant Molecular Biology and Biotechnology Group, has modified the gene responsible for its production.

The modified gene produced a protein that has a significantly reduced allergenic response, yet one still capable of boosting a person's immune response. These twin features are the key to a potential vaccine, or effective immunotherapy - the practice of giving allergic patients small, but increasing doses of allergen-containing extracts to boost their immunity to the allergen.

"Skin prick tests to assess the protein's safety suggest it is a significantly safer and more effective alternative to the current immunotherapy used to treat grass pollen allergies," says Associate Professor Prem Bhalla, joint leader of the group.

Their research is published in the latest European Journal of Immunology.

Current immunotherapy carries a significant risk of lethal side effects that include anaphylactic shock, a condition where the body rapidly becomes hypersensitive to an allergen.

"The symptoms of allergenic disease, like asthma, hayfever, allergic dermatitis and conjunctivitis, can be controlled with drugs, but specific immunotherapy is the only way to treat the causes of allergies that produce a potentially life threatening hypersensitivity (Type 1 allergies), says Bhalla.

Since its introduction in 1911, immunotherapy therapy has been subject to criticism and debate largely because the underlying immunological mechanisms of the human body are still unknown and because there has been no way of controlling the contents of the allergen-containing

Contact: Jason Major
University of Melbourne

Page: 1 2 3

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute
4. Potential cause of arthritis discovered
5. Potential of regenerative medicine explored
6. Potential therapy reported for children, adults with end-stage liver disease
7. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
8. Potential new anthrax therapy discovered
9. Potential gene therapy carriers created that mimic viruses, without the risk
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:

(Date:3/29/2019)... ... , ... In the wake of the success of IBBL’s ... biobanks was launched in July 2018, in an agreement between IBBL, the International ... Biotech Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA quantification ...
(Date:3/27/2019)... ... March 27, 2019 , ... NDA Partners Chief Executive Officer ... Health & Pharma Biotechnology Award as the Best Life Sciences Management & Contract ... individuals and companies whose accomplishments have proved evidence of extensive expertise and skills, ...
(Date:3/25/2019)... , ... March 25, 2019 , ... ... Visikol, a contract research organisation focused on advancing drug discovery, have announced a ... imaging. , Tissue clearing methods, which are essential to get a better view ...
Breaking Biology News(10 mins):
(Date:4/12/2019)... ... April 12, 2019 , ... ... neurotechnology and will educate about innovative tools and devices being used to enhance ... for more information. , This segment of Advancements will focus on Sound for ...
(Date:4/9/2019)... , ... April 09, 2019 , ... The American ... members of the Society's leadership team, including a new addition to the presidential line ... of their peers to join the Society's leadership team for a three-year term (2019-2021). ...
(Date:4/4/2019)... ... , ... LeadingBiotech, an exclusive event series bringing biopharma CEOs ... CEO conference to be held May 28-29, 2019 at Boston’s Four Seasons Hotel. ... and discussions from past, present and future change-makers. , LeadingBiotech, formerly ...
(Date:3/23/2019)... ... 2019 , ... uBiome has awarded microbiome research support in ... Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. Kingsley C. Anukam, ... Medical Laboratory Sciences and Deputy Provost, College of Health Sciences. The study hopes ...
Breaking Biology Technology:
Cached News: